23rd Congress of the European Hematology Association Stockholm, Sweden, June 14‐17, 2018
, 2018 HemaSphere, Volume 2, Issue S1, Page 1-1113, June 2018.
wiley +1 more source
A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development. [PDF]
J Pharmacokinet Pharmacodyn, 2023 Ruiz-Garcia A +14 more
europepmc +1 more source
Pleural effusion in hematological pathology. [PDF]
Cytojournal, 2021 Yerrapotu N +3 more
europepmc +1 more source
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors. [PDF]
Molecules, 2023 Tomarchio R +6 more
europepmc +1 more source
Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing. [PDF]
Cell Rep Med, 2023 Liu C +11 more
europepmc +1 more source
Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein
Haematologica, 2019 Haruka Shinohara +3 more
doaj +1 more source
Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review. [PDF]
Front Physiol, 2021 Santoro M +5 more
europepmc +1 more source
Iron Deficiency Caused by Intestinal Iron Loss-Novel Candidate Genes for Severe Anemia. [PDF]
Genes (Basel), 2021 Huettmann C +12 more
europepmc +1 more source
Establishment of a FDC-P1 Murine Cell Line with Human KIT N822K Gene Overexpression. [PDF]
Acta Naturae, 2020 Vagapova ER +5 more
europepmc +1 more source
TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations. [PDF]
PLoS Comput Biol, 2021 Liu Q, Xie L.
europepmc +1 more source